Ahan Chakraborty Profile - Zacks Equity Research Blogger
4 Followers
Ahan Chakraborty Zacks Equity Research
Financial Blogger
Success Rate
6 out of 13 ratings made a profit
Average Return
-14.80%
Average return per rating
Time Frame
Compare to
Copying Ahan Chakraborty's trades since 2024 and holding each position for 1 Year would result in 46.15% of your transactions generating a profit, with an average return of -14.8% per rating.
Stock Rating Distribution
63.89% Neutral
25.00% Bearish
11.11% Bullish
Distribution of Ahan Chakraborty's ratings
Additional Information
Main Sector:General
Geo Coverage:
Best Rating
The most profitable rating made by Ahan Chakraborty
Ahan Chakraborty's Stock Coverage
Novartis
Sep 12, 2024
Bullish
1Ratings
+10.50%
Roche Holding
Sep 12, 2024
Bullish
1Ratings
+9.00%
Regeneron
Jul 05, 2026
Bearish
1Ratings
-12.50%
Viking Therapeutics
Jul 20, 2026
Bearish
1Ratings
+17.70%
Eli Lilly & Co
Aug 19, 2026
Neutral
4Ratings
-11.35%
Editas Medicine
Aug 24, 2026
Neutral
1Ratings
―
0.00%
Intellia Therapeutics
Aug 24, 2026
Neutral
1Ratings
―
0.00%
Crispr Therapeutics AG
Aug 24, 2026
Neutral
1Ratings
―
0.00%
Beam Therapeutics
Aug 24, 2026
Neutral
1Ratings
―
0.00%
Keros Therapeutics
Aug 25, 2026
Neutral
1Ratings
―
0.00%
List of latest recommendations made by Ahan Chakraborty. Click to expand and see Ahan Chakraborty's performance on a particular stock
Disclaimer: TipRanks collects ratings of bloggers by scanning publicly available reports on financial websites and by receiving reports directly from the bloggers or from our users. The information displayed might not be accurate or up to date. The displayed ratings are made entirely at the sole discretion of the bloggers. TipRanks holds no liability over the bloggers information or opinions expressed on the site.